Investing.com - Alimera (NASDAQ: ALIM) reported first quarter EPS of $-0.070, $0.07 worse than the analyst estimate of $0.000. Revenue for the quarter came in at $26.31M versus the consensus estimate of $24.33M.
Alimera's stock price closed at $3.870. It is up 4.310% in the last 3 months and up 88.780% in the last 12 months.
Alimera saw 2 positive EPS revisions and 1 negative EPS revisions in the last 90 days. See Alimera's stock price’s past reactions to earnings here.
According to InvestingPro, Alimera's Financial Health score is "fair performance".
Check out Alimera's recent earnings performance, and Alimera's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar